NCT02719977 2023-08-04A Phase I Study of CX5461Canadian Cancer Trials GroupPhase 1 Completed41 enrolled
NCT01553071 2022-03-31Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed MalignanciesSouth Plains Oncology ConsortiumPhase 1 Terminated16 enrolled
NCT00003597 2014-07-24Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid TumorsChildren's Oncology GroupPhase 1 Completed16 enrolled